Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Breakthrough, pancreatic cancer

Digest more
Top News
Overview
 · 5h · on MSN
Cancer 'Holy Grail' discovered in breakthrough that doubled survival for deadly disease
A “game-changing” daily pill helped almost double survival time for patients with the most deadly major cancer.

Continue reading

 · 2h
‘Breakthrough’ pill doubles life expectancy for pancreatic cancer patients
 · 3h
Experimental pill nearly doubles survival in pancreatic cancer trial
 · 6h
‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.

Continue reading

Science News · 4h
A new pancreatic cancer pill may be a game changer for patients
 · 4h
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
NOLA.com
1y

New prostate cancer drug can extend life expectancy by 8 months, Baton Rouge doctor says

Dr. William Russell specializes in radiation oncology in Baton Rouge. He graduated from the University of Mississippi School of Medicine in 1984. Russell is double-board certified in internal medicine and radiation oncology, served six years in the U.S ...
Medical Xpress
6mon

Racial differences and prostate cancer treatment decisions

Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or Caucasian men, according to new research by Cedars-Sinai investigators published in the journal Prostate Cancer and Prostatic ...
Hosted on MSN
10mon

New research offers reassurance about localized prostate cancer prognosis

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ...
The Independent on MSN
16d

Prostate cancer screenings could save lives but experts warn of risks

Prostate cancer screenings could save lives but experts warn of major risks - Prostate cancer is the most common cancer among men in the UK, with more than 64,000 diagnoses anually
16d

Prostate cancer screening can save lives but ‘absolute benefit is small’, study says

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment
Hosted on MSN
10mon

Study Finds Most Prostate Cancer Patients Following NCCN Guidelines Live Long, Healthy Lives

PLYMOUTH MEETING, PA — New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer. The study shows that individuals treated ...
Medscape
11y

Overtreatment of Prostate Cancer Despite Limited Life Expectancy

National guidelines from associations such as the National Comprehensive Cancer Network (NCCN) and the American Urological Association recommend that men with a life expectancy of less than 10 years who have prostate cancer not be aggressively treated with ...
  • Privacy
  • Terms